231 – 240 of 364
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study
(2017) In Alzheimer's and Dementia: Translational Research and Clinical Interventions 3(3). p.393-401
- Contribution to journal › Article
- 2016
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
(2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2
- Contribution to journal › Published meeting abstract
-
Mark
Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Socioeconomic Predictors of the Employment of Migrant Care Workers by Italian Families Assisting Older Alzheimer's Disease Patients : Evidence from the Up-Tech Study
(2016) In Journals of Gerontology - Series B Psychological Sciences and Social Sciences 71(3). p.514-525
- Contribution to journal › Article
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
- Contribution to journal › Article
-
Mark
Amyloid beta aggregation kinetics : The role of intrinsic and extrinsic factors.
(2016)
- Thesis › Doctoral thesis (compilation)
-
Mark
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
- Contribution to journal › Article
-
Mark
Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer's disease patient with presenilin-1 mutation
- Contribution to journal › Article
